Baerveldt device showed better outcomes but required more interventions then Ahmed valve.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
The future of microbial keratitis treatment is bright
Ultraviolet light’s potential in ocular care extends beyond structural reinforcement to antimicrobial applications, especially for microbial keratitis
Higher Molar Dose and Its Translation into Clinical Practice
Diagnosing types of dry eye in patients with autoimmune disease
ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops (Myatro XL)
According to a press release, Myatro XL is the first 0.05% atropine eye drop for paediatric myopia control.
Investigating causes of diplopia to minimise morbidity and mortality
Canadian investigators urged quick neuro-ophthalmologic referrals to limit the progress of life- and vision-threatening conditions
Neurotech appoints Beth Marsh as chief commercial officer ahead of US product launch
The US FDA recently approved revakinagene taroretcel-lwey (ENCELTO) for the treatment of idiopathic macular telangiectasia type 2 (MacTel)